Currently, Biodesix Inc [BDSX] is trading at $1.43, up 7.89%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BDSX shares have gain 15.73% over the last week, with a monthly amount drifted -10.31%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Craig Hallum started tracking the stock with Buy rating on July 26, 2024, and set its price target to $3. On May 13, 2024, TD Cowen initiated with a Buy rating and assigned a price target of $2.80 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $3 on May 03, 2024. Morgan Stanley downgraded its rating to a Equal-Weight and reduced its price target to $11 on November 17, 2021. In a note dated November 23, 2020, Morgan Stanley initiated an Overweight rating and provided a target price of $20 on this stock.
This stock has fluctuated between a low of $1.11 and a high of $2.21 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Biodesix Inc [NASDAQ: BDSX] shares were valued at $1.43 at the most recent close of the market. An investor can expect a potential return of 109.79% based on the average BDSX price forecast.
Analyzing the BDSX fundamentals
Trailing Twelve Months sales for Biodesix Inc [NASDAQ:BDSX] were 65.56M which represents 34.54% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at -0.53%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -2.77 and Total Capital is -0.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3600 points at the first support level, and at 1.2850 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4900, and for the 2nd resistance point, it is at 1.5450.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Biodesix Inc [NASDAQ:BDSX] is 3.40. Also, the Quick Ratio is 3.30, while the Cash Ratio stands at 2.42. Considering the valuation of this stock, the price to sales ratio is 3.18, the price to book ratio is 7.49.
Transactions by insiders
Recent insider trading involved SCHULER JACK W, Director, that happened on Nov 21 ’24 when 100000.0 shares were purchased. Director, Kennedy Lawrence T. Jr completed a deal on Nov 21 ’24 to buy 35000.0 shares. Meanwhile, Director SCHULER JACK W bought 0.2 million shares on Nov 20 ’24.
